← Latest news 
Pharma exports top 31 billion in FY26 as US and China slump drives chaos
Economy
Published on 4 May 2026
March exports plunged 23% even as FY26 totals soared
Indian pharmaceutical exports crossed $31 billion in FY26 despite global headwinds. But March deliveries fell 23%, largely linked to weaker demand from the United States and China. Growth held up in markets such as Africa and Oceania, and vaccines led the fastest expansion, signaling a shift in where India’s drug makers are finding momentum.
- FY26 pharma exports exceed $31 billion overall
- March saw a sharp 23% drop tied to the US and China
- Africa and Oceania helped offset weaker core markets
- Vaccines are the fastest-growing export category
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times